Earnings
Wiley Earnings Preview: Investors Eye AI Revenue and Acquisition Progress
John Wiley & Sons reports fiscal Q1 results Thursday before market open, with expected earnings of $0.46 per share and revenue of $404.8 million.
L3Harris Raises Full-Year Guidance, Cites Strong Demand Across Missiles and Space
Shares of L3Harris Technologies remain near a 52-week low as the defense contractor outlines growth targets and a resurgent defense-industrial strategy.
Limoneira Q3 Loss Widens as Revenue Slips 7.8%, Avocado Prices Fall
Limoneira reported a $3M Q3 loss on $43.8M revenue, down from $1M last year, as avocado prices dropped 23% and lemon volumes ticked lower despite higher per-carton pricing.
Omnicell Focuses on Refresh Cycle at Wells Fargo Healthcare Conference
Omnicell discusses its Titan XT platform and OmniSphere at the Wells Fargo Healthcare Conference, highlighting its strategy for the refresh cycle and financial performance.
Live Nation says entertainment industry still in early innings of global growth
Live Nation reported $26.3 billion in trailing-twelve-month revenue and over 155 million tickets sold YTD, with CFO Joe Berchtold calling the sector early-stage on international expansion.
STMicroelectronics raises data-center revenue outlook, eyes big margin step
CFO says silicon-carbide output will hit €1.01 billion and fab closures late next year will lift gross margin more than 400 basis points.
Transcontinental posts mixed Q3 2026 results, expands raddar media reach
Adjusted EPS fell short of forecasts while revenue beat estimates; the retailer rolled out its raddar® platform to over 11 million Canadian households.
Glaukos Revenue Surges 42%, Epioxa Launches Amid Reimbursement Concerns
Glaukos reported 42% revenue growth to $613 million and guided for positive EPS by Q4 as Epioxa ramped, though reimbursement risks cloud the outlook for its iDose glaucoma device.
Argan Raises Quarterly Dividend 40% to $0.70, Marking Fourth Consecutive Raise
The Arlington-based power-industry contractor increased its quarterly payout to $0.70 a share, bringing the annual rate to $2.80, citing strong demand from datacenters and domestic manufacturing.
Cytokinetics Eyes Global HCM Expansion as Aficamten Momentum Builds
Cytokinetics reports 40% new-to-brand share for aficamten and outlines a European rollout plan, while confirmatory heart failure trial enrollment nears completion.
First Advantage Says Base Growth Hits 7%, Eyes Below 3x Leverage by 2027
First Advantage reported Q2 base growth of 7% at Citi's TMT conference, guided 4%-7% revenue CAGR through 2028, and said leverage should fall below 3x.
Burlington Stores Hits 52-Week Low as Retail Pressures Mount
Burlington Stores hit a 52-week low of $240.48, extending a 13.9% one-year decline. The company beat Q2 earnings but saw Deutsche Bank trim its price target.
Yatsen Q2 Revenue Surges 5% on Skincare Growth, Losses Widen
Skincare sales drive 71.5% of total revenue as color cosmetics slump; Chinese beauty firm reports wider GAAP net loss and issues flat-to-down Q3 guidance.
IMAX Sees Hit Films Fueling Growth as It Targets Untapped Global Screens
IMAX CFO and CMO outlined revenue growth, expanding box office demand, and a network still under half-filled at just 1,800 of a projected 4,500-location addressable market.
Innate Pharma Beats Q2 Forecasts but Shares Slip on Broader Market
The oncology-focused biotech reported a 22% earnings beat and modest revenue outperformance, but shares fell nearly 2% premarket as investors weighed pipeline milestones against ongoing losses.
DataMeds AI Settles $19M Debt Litigation for $450K
The NASDAQ-listed company retires about 364,099 shares and pays $450,000 cash to resolve nearly $19 million in outstanding debt claims tied to a 2023 agreement with Wellgistics LLC.
Robertet H1 2026: Fragrance Strength Offsets Flavor Weakness
French ingredient maker reports €444m revenue, missing forecasts as organic growth decelerates; full-year guidance lowered.
Earnings call transcript: Robertet H1 2026 revenue miss weighs on shares
Robertet's first‑half 2026 earnings call noted revenue fell short of expectations, pressuring its share price.
Huuuge Games Announces $120M Buyback Despite Q2 Revenue Slump
Warsaw-based mobile gaming publisher Huuuge Games announced a $120 million share repurchase program even as second-quarter revenue fell 13.4% year-over-year to $50.9 million.
Huuuge Games misses Q2 revenue, announces $120M share buyback
Huuuge Games reported a slight revenue miss for Q2 2026 but returned more capital to shareholders with a $120 million buyback, offsetting a broader market downturn.
T1 Energy Posts Wider Q2 Loss Despite Solar Module Output Growth
T1 Energy reported a $36.9 million net loss in Q2 2026 on $250.1 million in sales, even as it expanded its domestic solar strategy with acquisitions, tariff tailwinds, and G2 Austin construction progress.
Zscaler cites growth broadening across platforms, AI security at Citi TMT conference
Zscaler reported accelerating net new ARR growth to 17% in Q4 fiscal 2026, with revenue reaching $3.35 billion and AI security bookings surpassing $100 million over the trailing 12 months.
Asana Shifts to AI-Driven Platform; Revenue Growth Accelerates
Asana reported 10% revenue growth and beat guidance by $2.4M while unveiling five new AI products and a strategic pivot from collaborative work management to agentic work management.
D'Ieteren H1 Profit Surges as Belron Offsets Auto Unit Collapse
Belron's near two-thirds profit contribution masked a 67% collapse in the automotive segment, where margins compressed and goodwill impairments mounted.